Composition
- Active ingredients
- RIOCIGUAT 2MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RIOCIGUAT 1MG · TabletANDA211044-002 · Tentative approval
- RIOCIGUAT 2.5MG · TabletANDA211044-005 · Tentative approval
- RIOCIGUAT 1.5MG · TabletANDA211044-003 · Tentative approval
- RIOCIGUAT 2MG · TabletThis page
- RIOCIGUAT 2.5MG · TabletANDA211135-005 · Prescription
- RIOCIGUAT 1.5MG · TabletANDA211135-003 · Prescription
- RIOCIGUAT 0.5MG · TabletANDA211135-001 · Prescription
- RIOCIGUAT 2MG · TabletANDA211135-004 · Prescription
- RIOCIGUAT 1MG · TabletANDA211135-002 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA211044.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Riociguat
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Teva Pharms USA Inc
- Status
- Tentative approval
- FDA approval
- 30 Mar 2022
- Application
- ANDA211044-004